Bing

PRGO), as announced on April 8, 2015, as well as to Mylan on a standalone basis. Teva’s proposal would provide Mylan stockholders with consideration representing a 37.7% premium to the stock price of Mylan on April 7, 2015, which is the last day of ...
Business Wire · 4/21/2015
IDT Australia Limited (ASX:IDT) should trade firmer after securing an exclusive option agreement to acquire Perrigo Company's (NYSE: PRGO) Synthetic Conjugated ... reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North ...
Proactive Investors Australia · 1/28/2014
(PRGO). Companies in the health care industry are increasingly ... Health insurer Anthem Inc. (ANTM) said Friday that it agreed to acquire Cigna Corp. (CI) in a cash and stock transaction valued at $54.2 billion on an enterprise basis.
New Ratings · 7/26/2015
Hikma Pharmaceuticals (HIK.L) is buying Boehringer Ingelheim's U.S. generic drugs business for about $2.65 billion (1.69 billion pounds) in cash and stock, the latest in a ... proposed offer for Perrigo Company (PRGO.N). India's Lupin (LUPN.NS) also ...
Reuters · ByAastha Agnihotri andRoshni Menon · 2/8/2011
NEW YORK (Reuters) - Generic drugmaker Mylan Inc's (O:MYL) chief executive said on Thursday that acquiring Perrigo Co (N:PRGO) was not a must and that it had other options should Perrigo successfully fend off Mylan's $34 billion hostile offer. "There …
investing.com · 8/6/2015
Ireland-based drugmaker Perrigo Company plc (PRGO) on Wednesday reported a 57 percent decline in profit for the second quarter from last year as strong revenue growth was more than offset by higher expenses. However, both revenue and adjusted …
Realtime Business News · 8/5/2015
Fighting June gloom isn’t easy for investors — it’s not a great month for stocks. But there is an antidote. Investors have both irrational and rational reasons to be pretty blah about stocks during June. The old Wall Street saw “sell in May and go ...
USA TODAY MONEY · ByMatt Krantz · 6/1/2015
This could raise the likelihood that Mylan will succeed in its bid for Perrigo Co PRGO.O. Teva's deal with Allergan was unanimously approved by the boards of both companies and is expected to close in the first quarter of 2016. Teva Chief Executive Erez ...
The Peninsula · 7/27/2015
At first blush, Sam Isaly's investing style hardly sounds groundbreaking. When picking health-care stocks for the $1.4 billion Eaton Vance Worldwide Health Sciences Fund (ticker: ETHSX), Isaly, co-founder of the New York-based health-care investment firm ...
Barron's · ByJohanna Bennett · 3/18/2014
Perrigo Co. plc is a global healthcare supplier.It develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and active pharmaceutical ingredients.The company operates its business through following ...
4 Traders · 8/29/2015

Perrigo

Perrigo Company plc is an Irish international manufacturer of private label over-the-counter pharmaceuticals. The company’s shares are tra…
Perrigo Company plc is an Irish international manufacturer of private label over-the-counter pharmaceuticals. The company’s shares are traded on the NYSE and the Tel Aviv Stock Exchange; as a result of the merger with Agis Industries the company is a constituent of the TA-25 Index. Perrigo is the only non-Israeli company on the TA-25.
Data from: Wikipedia